Rinsho Ketsueki
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
Volume 40, Issue 12
Displaying 1-6 of 6 articles from this issue
  • Shuichi MIYAWAKI, Masahiro IMAMURA, Shoko KOBAYASHI, Kazunori OHNISHI, ...
    1999 Volume 40 Issue 12 Pages 1236-1244
    Published: 1999
    Released on J-STAGE: April 28, 2009
    JOURNAL RESTRICTED ACCESS
    We conducted a multicenter phase II clinical study of fludarabine phosphate, a new purine nucleotide analogue, in patients with chronic lymphocytic leukemia (CLL). Fludarabine phosphate was administered at a dose of 20 mg/m2/day intravenously for 5 days every 4 weeks as one course. Six courses as a maximum were repeated. The response rate was 38.5% (95% confidence intervals: 20.2% to 59.4%), with 1 complete remission and 9 partial remissions out of 26 treated patients. Major drug-related adverse reactions were fever, nausea, weakness, and paresthesia of the fingers; as a grade-3 reaction, varicella was also reported. Neutropenia and thrombocytopenia were observed as manifestations of hematologic toxicity. Clinical laboratory test results revealed abnormalities in hepatic function, including increased GPT, but none of these was rated grade 3 or 4.
    Download PDF (620K)
  • Katsumichi FUJIMAKI, Atsuo MARUTA, Juichi TANABE, Chizuko HASHIMOTO, F ...
    1999 Volume 40 Issue 12 Pages 1245-1251
    Published: 1999
    Released on J-STAGE: April 28, 2009
    JOURNAL RESTRICTED ACCESS
    This study was undertaken to identify the factors influencing pulmonary function in patients who underwent hematopoietic stem cell transplantation (HCT). Pulmonary function tests were evaluated before and after HCT in 51 adult patients who underwent HCT between 1993 and 1998. The patients with hematologic malignacies were given total body irradiation. Graft-versus-host disease (GVHD) prophylaxis consisted of cyclosporine A and short-term methotrexate. Six patients suffered from acute GVHD above grade II and 27 patients suffered from chronic GVHD. The post-transplant % diffusing capacity (%DLco) 100 days after HCT was significantly lower than pretransplant values (82±21% versus 71±15%, p<0.01). The %DLco at 100 days was significantly lower in patients with chronic GVHD than in patients without chronic GVHD (66±16% versus 77±9%, p<0.05). These findings suggested chronic GVHD is related to the decreased %DLco values abserved 100 days after HCT.
    Download PDF (496K)
  • Toshiyuki BOHGAKI, Atsushi NOTOYA, Masaya MUKAI, Michifumi KOHNO
    1999 Volume 40 Issue 12 Pages 1252-1257
    Published: 1999
    Released on J-STAGE: April 28, 2009
    JOURNAL RESTRICTED ACCESS
    A 30-year-old man was admitted to our hospital with the chief complaints of fever and pain in the right shoulder, axilla, and inguinocrural region. Computed tomography, magnetic resonance imaging, 67Ga-scintigraphy, and bone-scintigraphy revealed osteolytic lesions in the ribs and right ilium. Biopsy specimens from lesions in the right ilium confirmed the diagnosis of CD 30-positive anaplastic large cell lymphoma. The patient was treated with 6 courses of CHOP therapy followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation. He achieved and remained in remission with no evidence of relapse 14 months later.
    Download PDF (813K)
  • Hidetsugu MIHARA, Yoshiro KATO, Yoshifumi TOKURA, Yoshihiko HATTORI, A ...
    1999 Volume 40 Issue 12 Pages 1258-1264
    Published: 1999
    Released on J-STAGE: April 28, 2009
    JOURNAL RESTRICTED ACCESS
    A 32-year-old woman in the 16th week of pregnancy was admitted to our hospital because of high fever. Laboratory findings disclosed pancytopenia and extremely elevated serum LDH and ferritin levels. Coagulation tests showed disseminated intravascular coagulation. Serum soluble interleukin-2 receptor, tumor necrosis factor-α, and interleukin-6 levels were high, but serum interferon-γ was below the detectable limit. Reactive Epstein-Barr virus (EBV) infection was diagnosed on the basis of a high titer of IgG antibodies to the EBV capsid antigen and early antigen. EBV was demonstrated in the peripheral blood and bone marrow cells by polymerase chain reaction. Mature histiocytosis and hemophagocytosis were detected in the bone marrow. A diagnosis of EBV-associated hemophagocytic syndrome (EBV-AHS) was made. Neither prednisolone (PSL 30 mg/day, P.O.) nor methylprednisolone (m-PSL) pulse therapy (1,000 mg/day for 3 days) induced a response. Thereafter, treatment with m-PSL pulse therapy (1,000 mg/day for 3 days) and i.v. administrations of high-dose immunoglobulin (20 g/day for 3 days) in combination with acyclovir (750 mg/day) and gabexate mesilate (2 g/day) induced remission of the disease. Maintenance therapy consisted of PSL (5 mg/day, P.O.) and camostat mesilate (600 mg/day, P.O.). The patient delivered a healthy male infant in the 35th week of pregnancy via natural birth. Reports of pregnant women with EBV-AHS are rare, and the choice of therapy has not yet been established. The present case study suggested the above combination treatment is useful and safe, and capable of changing the fulminant course of EBV-AHS during pregnancy without the use of anticancer drugs.
    Download PDF (550K)
  • Hiroko OHNISHI, Tomohiko KAMIMURA, Hisashi GONDO, Takashi OKAMURA, Yos ...
    1999 Volume 40 Issue 12 Pages 1265-1270
    Published: 1999
    Released on J-STAGE: April 28, 2009
    JOURNAL RESTRICTED ACCESS
    We encountered a 65-year-old woman with diffuse large B-cell lymphoma showing t(8;14)(q24;q32) and c-myc gene rearrangement that developed following 12 years of melphalan-based chemotherapy for multiple myeloma. Short-term remission was obtained by CHOP chemotherapy. However, shortly thereafter the patient died of an aggressive progression of lymphoma. It was suspected that the lymphoma was a secondary malignancy related to the treatment with cytotoxic agents and radiation for prolonged multiple myeloma. The chromosomal abnormality t(8;14)(q24;q32) is rare in secondary malignancies. Overexpression of c-myc by gene rearrangement may be associated with clinical courses manifested by the rapid progression of lymphoma.
    Download PDF (780K)
feedback
Top